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ABSTRAK
Osteoartritis ialah penyakit degeneratif sendi yang kerap berlaku pada warga tua 
seluruh dunia. Prevalen penyakit ini terus meningkat dan menjadi penyebab utama 
kesakitan serta hilang upaya pada umur tua. Osteoartritis boleh didiagnos melalui 
X-ray filem ringkas berserta tanda klinikal dan ciri-ciri struktur. Ketidakseimbangan 
antara sintesis dan degradasi kartilaj telah dinyatakan terlibat dengan perkembangan 
osteoarthritis, yang dikaitkan dengan kematian kondrosit. Walaupun terdapat 
banyak sitokin dan petanda biologi yang berkait dengan penyakit ini, ulasan ini 
akan menyediakan latarbelakang dan perbincangan petanda-petanda biologi 
yang diketahui terlibat dengan perkembangan osteoarthritis termasuk hasil akhir 
‘glycation’ lanjutan, glutation dan glikosaminoglikan.
Kata kunci: petanda-petanda biologi, penyakit degeneratif sendi, osteoartritis
ABSTRACT
Osteoarthritis is the most common degenerative joint disease that develops in the 
elderly. The worldwide prevalence continues to rise, leading to pain and disability 
in older ages. Osteoarthritis can be diagnosed by using plain film X-ray combined 
with clinical appearance and structural features. The imbalance between cartilage 
synthesis and degradation has been explained in the development of osteoarthritis, 
which is associated with chondrocyte death. There are many cytokines and 
biological markers related to the disease. The present review provides a background 
and discusses the known biological markers that are related to developing 
osteoarthritis. These include advance glycation end products, glutathione and 
glycosaminoglycans. 
Keywords: biological markers, degenerative joint disease, osteoarthritis
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inflammatory cytokines. The ligaments 
are often lax and there is muscle 
weakness. Currently, the diagnosis 
of OA comprises both clinical 
appearance and structural features. 
Plain film radiograph is widely used 
as a gold standard to define the 
damaged articular cartilage (Gahunia 
et al. 1995). The common radiographic 
features including decrease joint space, 
formation of osteophyte, subchondral 
thickness or sclerosis and abnormalities 
of bone density.
 The etiology of osteoarthritis is not 
well understood and has multifactorial 
association (Garstang & Stitik 2006; 
Henrotin 2012; Hochberg 2012). Age 
is the most important risk factor of 
osteoarthritis and the relationship 
between aging and OA is well known 
but the mechanisms are still not fully 
understood (Loeser 2010). At the cell 
and tissue level, articular cartilage 
consist of  few cells and highly 
surrounding extracellular matrix (ECM). 
Chondrocyte is present in articular 
cartilage and involved in maintaining 
the balance of matrix synthesis and 
degradation (Goggs  et al. 2003). 
Many previous studies observed 
the chondrocyte death related to 
progressive loss of hyaline articular 
cartilage which report an increased 
amount of apoptotic program cell death 
(Aigner et al. 2001; Almonte-Becerril et 
al. 2010; Blanco et al.  1998; Dang & 
Kim 2009). Thomas investigated the 
incidence of chondrocyte apoptosis 
in equine articular cartilage specimens 
and observed the relationship between 
the process of chondrocyte death and 
the degree of cartilage degradation. 
They demonstrated that chondrocyte 
INTRODUCTION
Osteoarthritis (OA) is a group of 
degenerative joint diseases (DJD) and 
one of the most common disorders 
worldwide which leads to pain and 
disability in the elderly (Arden & 
Nevitt 2006; Garstang & Stitik 2006). 
Osteoarthritis is considered by chronic 
loss of hyaline cartilage at the joint 
articulation and osteophytes formation 
in the affected joints which leads 
to progressive pain and limitation 
of movement and function in aged 
individuals (Gahunia et al. 1995; 
Hayashi et al. 2012; Henrotin 2012). The 
risk factors associated with OA include 
age, sex, history of joint injury, obesity, 
genetic factors, and mechanical 
factors, containing abnormal joint 
structure and malalignment (Garstang 
& Stitik 2006). The incidence of OA 
continues to increase with age and the 
prevalence of osteoarthritis is greater 
in men than in women in most joints 
before 50 yrs of age. Furthermore after 
50 yrs, women are more often affected 
than men, especially in the hand, foot, 
and knee osteoarthritis (Van der Kraan 
2012). Osteoarthritis can be defined by 
pathology of joint structure comprising 
chronic loss of hyaline articular 
cartilage, changes in the subchondral 
bone; the bone under the cartilage, 
development of osteophyte and 
increased bone sclerosis and thickness 
of the bone under the cartilage (Shane 
Anderson & Loeser 2010; Gahunia et 
al. 1995).  
 Not only change of joint structure, 
the connective tissue surrounding 
the joint can be affected. The 
synovial membrane has increase in 
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apoptosis is associated with degree 
of cartilage matrix damage and 
mechanical loading environment of the 
joint is a significant positive correlation 
between severity of OA and apoptosis 
(Thomas et al. 2007). Chondrocyte 
death has been observed during the 
development of OA but whether this 
is an early or late event is still unclear. 
Therefore, the breakdown of cartilage 
during the OA pathogenesis is related 
to chondrocytes death and the loss of 
ECM (Almonte-Becerril et al. 2010).
REACTIVE OXYGEN SPECIES 
(ROS)
Reactive oxygen species (ROS) are free 
radicals, which play an important role 
in the aging process in both human 
and animal models (Afonso et al. 2007; 
Ziskoven et al. 2010). There are group 
of free radicals oxygen molecules such 
as hydroxyl group (OH-), hydrogen 
peroxide (H2O2), superoxide anion (O
-
2) and nitric oxide (NO) (Henrotin et al. 
2003; Lepetsos & Papavassiliou 2016). 
In the articular cartilage, chondrocytes 
generate several forms of ROS such 
as superoxide, hydrogen peroxide, 
reactive nitrogen species and nitric 
oxide. In normal process, there are 
various anti-oxidants which control the 
levels of ROS (Biemond et al. 1984). 
There are antioxidant system in the 
human body which include enzymatic 
and non-enzymatic antioxidants, 
such as superoxide dismutase (SOD), 
catalase (CAT), glutathione peroxidise 
(GPX), glutathione (GSH), ascorbic acid 
(vitamin C), α-tocopherol (vitamin E) 
and carotinoids.
 Oxidative stress can also disturbance 
in the antioxidant defenses mechanism 
against the level of ROS, which results 
in cellular damage and disruption 
of redox homeostasis leading to 
chondrocyte senescent by causing 
destruction of proteins, lipids, and 
DNA directly (Henrotin et al. 2005). 
Increase in ROS level is related to 
aging process and plays an important 
role in the progression of OA. There 
are various increasing inflammatory 
cytokines in OA such as IL-1, IL-6 and 
TNF-α, which encourage production 
of ROS as a result of increased level of 
MMPs (Loeser 2009; Loeser 2010).
THE DIAGNOSIS OF 
OSTEOARTHRITIS
Kellgren and Lawrence in 1957 were the 
first to use radiographic grading system 
using plain film radiograph. Nowadays 
it is the gold-standard for identifying 
the structural changes in joint structure 
in patient with OA (Altman & Gold 
2007). Radiographic methods of knee 
OA have usually assessed the disease 
progression, its least expensive method 
for detecting joint structural change 
in patients with OA. The severity of 
disease normally determined by using 
the Kellgren and Lawrence grading 
system, the most widely used and 
accepted standard for diagnosis of 
radiographic OA. The grading system 
consists of 4 grade scales, for grade of 
0 suggests that no structural changes 
of OA and grade 4 is defined as the 
severe one. The grading scale has been 
analyzed for illustrating the progression 
of OA comprising both osteophyte 
formation and decreased in joint space. 
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PATHOGENESIS OF 
OSTEOARTHRITIS
Typical characteristics of osteoarthritis 
are the progressive loss and damage 
of hyaline articular cartilage in the 
articulation in the affected joint. 
The homeostasis of cartilage matrix 
synthesis and degradation are the 
main causes of disease progression 
(Aigner et al. 2001). The mechanism of 
matrix degradation is still unclear but 
associated with both environmental 
and genetic factors. There are many 
factors related the disease such as the 
change of metabolic, biochemical 
and metabolic homeostasis. In OA 
cartilage, not only the chondrocytes are 
produced many cytokines and growth 
factors but also the synovial tissue. 
On the anabolic process, the synthesis 
of extracellular matrix is stimulated 
by insulin-like growth factor (IGF)-1, 
transforming growth factor (TGF)-b, 
fibroblast growth factors (FGFs) and 
bone morphogenetic proteins (BMPs) 
(Aigner et al. 2001). From the catabolic 
process, Matrix metalloproteinase 
(MMP) is increased and produced 
the inflammatory cytokines including 
interleukin (IL)-1, IL-17 and IL-18 and 
tumor necrosis factor (TNF)-a, which 
leads to decrease of aggrecan and 
matrix components, as a result of 
cartilage matrix degradation (Afonso 
et al. 2007; Blanco et al. 1998; Loeser 
2010).
 There are biochemical and structural 
changes in OA cartilage including 
The increasing of water content and 
the matrix macro molecules such 
as aggrecan can be decrease. The 
structure of the collagen is damaged, 
which leads to reduced stiffness and 




Nowadays, many studies focused on 
damaging effects of free radicals such 
as reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) in 
osteoarthritis (Valko et al. 2007; Ziskoven 
et al. 2010). Glutathione (GSH) is one of 
an endogenous important intracellular 
anti-oxidant, plays a role in the 
detoxification of oxygen free radicals. 
The increasing of ROS levels, the ratio 
of oxidized to reduced glutathione is 
changed (Loeser 2010). Glutathione 
is performed in the cytosol of various 
cell types and delivered to extracellular 
matrix and other organelles for 
example, mitochondria, endoplasmic 
reticulum and the nucleus (Bertrand 
et al. 2010; Blanco et al. 2004). GSH 
occurs not only the reduced state 
(GSH) but also oxidized state (GSSG). 
The ratio of GSH/GSSG is necessary to 
maintain normal functioning and is a 
good measure of oxidative stress of a 
tissue and organism (Regan et al. 2008). 
The protective effect of glutathione 
against the oxidative stress such as the 
glutathione is a importance co-factor of 
numerous enzymes for against oxidative 
stress, including glutathione peroxidase 
(GPx), glutathione transferase and 
others. There are previous studies about 
glutathione associated osteoarthritis 
as shown in Table 1. The glutathione 
represents the major cellular redox 
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buffer and therefore is a representative 




Glycosaminoglycan (GAG) are one 
of the most important components 
of extracellular matrix (ECM) and 
play multiple roles in different tissues 
and organs, associated with other 
pathological conditions such as 
osteoarthritis, inflammation, diabetes 
mellitus, spinal cord injury and cancer. 
GAGs are polysaccharides, devided in 
five major groups including: chondroitin 
sulfate (CS), dermatan sulfate (DS), 
heparan sulfate (HS), keratan sulfate (KS) 
and hyaluronan (HA) (Studelska et al. 
2006). The mechanism of extracellular 
matrix degradation in joint diseases 
is not fully understood but the main 
factor associated is the reactive oxygen 
species (ROS). An increased level of 
ROS as a result of decreased levels of 
GSH leading to reduce the synthesis 
component of the articular cartilage, 
which are proteoglycan and hyaluronic 
acid. Inerot et al. (1978) investigated 
the structural change of proteoglycans 
of aging cartilage in the degenerated 
cartilage of osteoarthritis, found that 
proteoglycans from the degenerated 
cartilage were smaller than those from 
the same-age normal cartilage and 
had partially lost their ability to bind 
to hyaluronic acid and form aggregates 
(Inerot et al. 1978). The recent studies 
about glycosaminoglycans associated 
osteoarthritis as shown in Table 1. The 
structural and composition changes of 
glycosaminoglycan in OA cartilages 
could be the result of changes in both 
the catabolic and anabolic process of 
chondrocytes during the progression of 
the disease.
ADVANCED GLYCATION END 
PRODUCTS (AGES)
Advanced glycation end products 
(AGEs) are the macromolecules and 
formed in body during the process 
of normal aging, suggesting the 
association with development of 
osteoarthritis. AGEs produces from 
non-enzymatic glycation of proteins 
and lipids leading to formation of 
collagen cross-links (Nah et al. 2007; 
Yang et al. 2015) affects the structural 
properties of cartilage as a result of 
increased stiffness and brittle in the 
hyaline articular cartilage (Chen et al. 
2005). Increasing of AGEs in cartilage 
involve in cellular activities such as bone 
remodeling process, which increase of 
abnormal proliferation, differentiation, 
and apoptosis of bone cells, such as 
osteoclasts (OCs), osteoblasts, and 
osteocytes (Yaffe et al. 2011; Yang 
et al. 2015). DeGroot et al. (2001) 
investigated the relationship between 
accumulation of AGE levels and 
chondrocyte turn over of proteoglycans 
in articular cartilage of human. 
They found that the accumulation 
of AGE increased with aged and its 
has negatively affects synthesis and 
degradation of proteoglycan as a result 
of development of OA (DeGroot et 
al. 2001). It has been suggested that, 
increased of advanced glycation end 
products (AGEs) in cartilage related to 
aging and responsible for decreased 
the ability of the cartilage to remodel 
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its extracellular matrix, predisposing 
factor for the development of cartilage 
damage in OA (Viguet-Carrin et al. 
2008). The previous studies of AGEs 
associated osteoarthritis as shown in 
Table 1.  
CONCLUSION
Osteoarthritis is considered as a group 
of degenerative disorder, which leads 
to pain and limitation of functional 
movement in affected joint. The 
etiology and mechanism are still unclear 
but associated with many factors.
In the cellular level, there are many 
cytokines and growth factors involve 
in the mechanism of osteoarthritis. In 
this review, we presented the literature 
review of osteoarthritis and biological 
marker associated the pathology.
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